Search Results - "Shen, Marina W H"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Inhibition of Cytosolic Phospholipase A2α: Hit to Lead Optimization by McKew, John C, Foley, Megan A, Thakker, Paresh, Behnke, Mark L, Lovering, Frank E, Sum, Fuk-Wah, Tam, Steve, Wu, Kun, Shen, Marina W. H, Zhang, Wen, Gonzalez, Mario, Liu, Shanghao, Mahadevan, Anu, Sard, Howard, Khor, Soo Peang, Clark, James D

    Published in Journal of medicinal chemistry (12-01-2006)
    “…Compound 1 was previously reported to be a potent inhibitor of cPLA2α in both artificial monomeric substrate and cell-based assays. However, 1 was inactive in…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening by Ramarao, Manjunath K., Murphy, Elizabeth A., Shen, Marina W.H., Wang, Yuren, Bushell, Kristen N., Huang, Nelson, Pan, Ning, Williams, Cara, Clark, James D.

    Published in Analytical biochemistry (01-08-2005)
    “…A novel fluorescent assay to continuously monitor fatty acid amide hydrolase (FAAH) activity that is simple, sensitive, and amenable to high-throughput…”
    Get full text
    Journal Article
  11. 11

    The cPLA2α inhibitor efipladib decreases nociceptive responses without affecting PGE2 levels in the cerebral spinal fluid by Nickerson-Nutter, Cheryl L, Goodwin, Debra, Shen, Marina W H, Damphousse, Christy, Duan, Weili, Samad, Tarek A, McKew, John C, Lee, Katherine L, Zaleska, Margaret M, Mollova, Nevena, Clark, James D

    Published in Neuropharmacology (01-03-2011)
    “…The contribution of central PGE(2) levels to the nociceptive response in rats was assessed and the effects of the selective cPLA(2)α inhibitor efipladib, and…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Thermodynamic characterization of cytosolic phospholipase A2 alpha inhibitors by Ramarao, Manjunath K, Shen, Marina W H, Murphy, Elizabeth A, Duan, Weili, Zhao, Yajuan, McKew, John, Lee, Katherine L, Thakker, Paresh, Behnke, Mark L, Clark, James D

    Published in Analytical biochemistry (15-12-2008)
    “…Cytosolic phospholipase A(2) alpha (cPLA(2)alpha, type IVA phospholipase) acts at the membrane surface to release free arachidonic acid, which is metabolized…”
    Get full text
    Journal Article
  14. 14

    Reactions of Functionalized Sulfonamides: Application to Lowering the Lipophilicity of Cytosolic Phospholipase A2α Inhibitors by Chen, Lihren, Wang, Weiheng, Lee, Katherine L, Shen, Marina W. H, Murphy, Elizabeth A, Zhang, Wen, Xu, Xin, Tam, Steve, Nickerson-Nutter, Cheryl, Goodwin, Debra G, Clark, James D, McKew, John C

    Published in Journal of medicinal chemistry (26-02-2009)
    “…The cPLA2α inhibitors we reported earlier were potent in both isolated enzyme and rat whole blood assays but have high plogD7.4. To address these issues,…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Inhibition of cytosolic phospholipase A2alpha: hit to lead optimization by McKew, John C, Foley, Megan A, Thakker, Paresh, Behnke, Mark L, Lovering, Frank E, Sum, Fuk-Wah, Tam, Steve, Wu, Kun, Shen, Marina W H, Zhang, Wen, Gonzalez, Mario, Liu, Shanghao, Mahadevan, Anu, Sard, Howard, Khor, Soo Peang, Clark, James D

    Published in Journal of medicinal chemistry (12-01-2006)
    “…Compound 1 was previously reported to be a potent inhibitor of cPLA(2)alpha in both artificial monomeric substrate and cell-based assays. However, 1 was…”
    Get full text
    Journal Article
  20. 20